Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.82 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.67 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.61 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.60 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.55 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL342881 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL55273 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL15846208 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL539797 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL55274 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL15846853 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL15650316 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL170160 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL318616 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL15846211 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1391193-B1 | Silicone-in-water emulsion comprising specific polyether-polydimethylsiloxane copolymer | BEIERSDORF AG (DE) | 2007-01-03 | — | — | EP | claimed |
| WO-2026100477-A1 | FIRE EXTINGUISHING COMPOSITION | 花王株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20260130832-A1 | EMULSION COMPOSITION | AJINOMOTO CO., INC. (JP) | 2026-05-14 | — | — | US | disclosed |
| EP-3808330-B1 | W/O EMULSION COMPOSITION CONTAINING CERAMIDES | KAO CORP (JP) | 2025-08-27 | — | — | EP | disclosed |
| CN-113811283-B | Liquid oil-in-water composition | 株式会社高丝 | 2025-01-28 | — | — | CN | disclosed |
| CN-118845537-A | Sheet-like cosmetic | 花王株式会社 | 2024-10-29 | — | — | CN | disclosed |
| CN-118660703-A | Novel highly sustainable compositions for modulating human skin gene expression and methods of producing the same | 维索利斯技术股份有限公司 | 2024-09-17 | — | — | CN | disclosed |
| WO-2024142846-A1 | COSMETIC COMPOSITION | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| US-20240099955-A1 | SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF | HTL BIOTECHNOLOGY INNOVATION INC. | 2024-03-28 | — | — | US | disclosed |
| US-11896688-B2 | W/O emulsion composition | KAO CORPORATION (JP) | 2024-02-13 | — | — | US | disclosed |
| CN-1852697-A | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | CIBA SC HOLDING AG (CH) | 2006-10-25 | — | — | CN | disclosed |
| US-20050002879-A1 | External skin compositions | KAO CORPORATION (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-1407752-A1 | COMPOSITE POWDERS AND SKIN PREPARATIONS FOR EXTERNAL USE CONTAINING THE SAME | Shiseido Co., Ltd. (JP) | 2004-04-14 | — | — | EP | disclosed |
| EP-1384482-A1 | EXTERNAL SKIN COMPOSITIONS | Kanebo, Limited (JP) | 2004-01-28 | — | — | EP | disclosed |
| US-6238621-B1 | (A) AT LEAST ONE AMIDO ACID OR SALT THEREOF AND (B) AT LEAST ONE OF AN ARYLTRIAZOLE OR 3-AMINO-1,2,4-TRIAZOLE | SOLUTIA INC. | 2001-05-29 | — | — | US | disclosed |
| WO-1999061683-A1 | CORROSION INHIBITING COMPOSITIONS AND AQUEOUS METAL WORKING COMPOSITIONS | SOLUTIA INC. (US) | 1999-12-02 | — | — | WO | disclosed |
| EP-0388582-B2 | Cosmetic composition | KOSE CORP (JP) | 1998-04-08 | — | — | EP | disclosed |
| EP-0729781-A1 | SURFACTANT, AND EMULSION COSMETIC AND LIPOSOME EACH CONTAINING THE SAME | Ikemoto, Takeshi (JP) | 1996-09-04 | — | — | EP | disclosed |
| US-5219560-A | Acryl-siloxane graft and low viscosity silicone oil | KOBAYASHI KOSE CO., LTD. (JP) | 1993-06-15 | — | — | US | disclosed |
| EP-0388582-A2 | Cosmetic composition | Kosé Corporation (JP) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260130832-A1 | EMULSION COMPOSITION | DGKA, DGKG, ADH1A | NOD1 4630/4885PLA2G2C 951/4885PLA2G10 528/4885 |
| US-11896688-B2 | W/O emulsion composition | SGMS2, SGMS1, DEGS1 | NOD1 4572/4885PLA2G2C 83/4885PLA2G10 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.